Lisa Richters

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

Philipp Harter, Jan Hauke, Florian Heitz et al. · PLoS ONE · 2017 · 133 citations · Full text

Life Sciences, Genetics, Oncology +17

BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer

Nana Weber‐Lassalle, Jan Hauke, Juliane Ramser et al. · Breast Cancer Research · 2018 · 132 citations · Full text

Medicine, Genetics, Oncology +17

Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility

Irene Catucci, Ana Osório, Brita Arver et al. · Genetics in Medicine · 2017 · 93 citations · Full text

Life Sciences, Genetics, Hematology +15

Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer

Nana Weber‐Lassalle, Julika Borde, Konstantin Weber‐Lassalle et al. · Breast Cancer Research · 2019 · 64 citations · Full text

Life Sciences, Genetics, Oncology +17

Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)

Jan Hauke, Eric Hahnen, Stephanie Schneider et al. · Journal of Medical Genetics · 2019 · 43 citations · Full text

Medicine, Genetics, Oncology +17